A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes

Details 詳細情報について

• CRID

  1360292620319153792

• DOI

  10.3810/pgm.2010.05.2138

• ISSN

  19419260

  00325481

• Web Site

  http://www.tandfonline.com/doi/pdf/10.3810/pgm.2010.05.2138

• Data Source

  • Crossref